CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells

Ilaria Schiavoni, Carolina Scagnolari, Alberto L Horenstein, Pasqualina Leone, Alessandra Pierangeli, Fabio Malavasi, Clara M Ausiello, Giorgio Fedele

Research output: Contribution to journalArticle

Abstract

Respiratory syncytial virus (RSV) is the most common cause of hospitalization due to bronchiolitis in infants. Although the mechanisms behind this association are not completely elucidated, they appear to involve an excessive immune response causing lung pathology. Understanding the host response to RSV infection may help in the identification of targets for therapeutic intervention. We infected in-vitro human monocyte-derived dendritic cells (DCs) with RSV and analysed various aspects of the cellular response. We found that RSV induces in DCs the expression of CD38, an ectoenzyme that catalyses the synthesis of cyclic ADPR (cADPR). Remarkably, CD38 was under the transcriptional control of RSV-induced type I interferon (IFN). CD38 and a set of IFN-stimulated genes (ISGs) were inhibited by the anti-oxidant N-acetyl cysteine. When CD38-generated cADPR was restrained by 8-Br-cADPR or kuromanin, a flavonoid known to inhibit CD38 enzymatic activity, RSV-induced type I/III IFNs and ISGs were markedly reduced. Taken together, these results suggest a key role of CD38 in the regulation of anti-viral responses. Inhibition of CD38 enzymatic activity may represent an encouraging approach to reduce RSV-induced hyperinflammation and a novel therapeutic option to treat bronchiolitis.

Original languageEnglish
Pages (from-to)122-131
Number of pages10
JournalImmunology
Volume154
Issue number1
DOIs
Publication statusPublished - May 2018

Fingerprint

Respiratory Syncytial Viruses
Dendritic Cells
Monocytes
Bronchiolitis
Respiratory Syncytial Virus Infections
Interferon Type I
Flavonoids
Oxidants
Interferons
Genes
Cysteine
Hospitalization
Pathology
Lung
Therapeutics

Keywords

  • ADP-ribosyl Cyclase 1/antagonists & inhibitors
  • Antiviral Agents/therapeutic use
  • Cells, Cultured
  • Cyclic ADP-Ribose/metabolism
  • Dendritic Cells/drug effects
  • Enzyme Activation
  • Enzyme Inhibitors/therapeutic use
  • Host-Pathogen Interactions
  • Humans
  • Interferon Type I/metabolism
  • Membrane Glycoproteins/antagonists & inhibitors
  • Oxidative Stress
  • Reactive Oxygen Species/metabolism
  • Respiratory Syncytial Virus Infections/drug therapy
  • Respiratory Syncytial Virus, Human/immunology
  • Signal Transduction

Cite this

CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells. / Schiavoni, Ilaria; Scagnolari, Carolina; Horenstein, Alberto L; Leone, Pasqualina; Pierangeli, Alessandra; Malavasi, Fabio; Ausiello, Clara M; Fedele, Giorgio.

In: Immunology, Vol. 154, No. 1, 05.2018, p. 122-131.

Research output: Contribution to journalArticle

Schiavoni, I, Scagnolari, C, Horenstein, AL, Leone, P, Pierangeli, A, Malavasi, F, Ausiello, CM & Fedele, G 2018, 'CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells', Immunology, vol. 154, no. 1, pp. 122-131. https://doi.org/10.1111/imm.12873
Schiavoni, Ilaria ; Scagnolari, Carolina ; Horenstein, Alberto L ; Leone, Pasqualina ; Pierangeli, Alessandra ; Malavasi, Fabio ; Ausiello, Clara M ; Fedele, Giorgio. / CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells. In: Immunology. 2018 ; Vol. 154, No. 1. pp. 122-131.
@article{d76c1cfb054d4f6ebc5e4fa188989be9,
title = "CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells",
abstract = "Respiratory syncytial virus (RSV) is the most common cause of hospitalization due to bronchiolitis in infants. Although the mechanisms behind this association are not completely elucidated, they appear to involve an excessive immune response causing lung pathology. Understanding the host response to RSV infection may help in the identification of targets for therapeutic intervention. We infected in-vitro human monocyte-derived dendritic cells (DCs) with RSV and analysed various aspects of the cellular response. We found that RSV induces in DCs the expression of CD38, an ectoenzyme that catalyses the synthesis of cyclic ADPR (cADPR). Remarkably, CD38 was under the transcriptional control of RSV-induced type I interferon (IFN). CD38 and a set of IFN-stimulated genes (ISGs) were inhibited by the anti-oxidant N-acetyl cysteine. When CD38-generated cADPR was restrained by 8-Br-cADPR or kuromanin, a flavonoid known to inhibit CD38 enzymatic activity, RSV-induced type I/III IFNs and ISGs were markedly reduced. Taken together, these results suggest a key role of CD38 in the regulation of anti-viral responses. Inhibition of CD38 enzymatic activity may represent an encouraging approach to reduce RSV-induced hyperinflammation and a novel therapeutic option to treat bronchiolitis.",
keywords = "ADP-ribosyl Cyclase 1/antagonists & inhibitors, Antiviral Agents/therapeutic use, Cells, Cultured, Cyclic ADP-Ribose/metabolism, Dendritic Cells/drug effects, Enzyme Activation, Enzyme Inhibitors/therapeutic use, Host-Pathogen Interactions, Humans, Interferon Type I/metabolism, Membrane Glycoproteins/antagonists & inhibitors, Oxidative Stress, Reactive Oxygen Species/metabolism, Respiratory Syncytial Virus Infections/drug therapy, Respiratory Syncytial Virus, Human/immunology, Signal Transduction",
author = "Ilaria Schiavoni and Carolina Scagnolari and Horenstein, {Alberto L} and Pasqualina Leone and Alessandra Pierangeli and Fabio Malavasi and Ausiello, {Clara M} and Giorgio Fedele",
note = "{\circledC} 2017 John Wiley & Sons Ltd.",
year = "2018",
month = "5",
doi = "10.1111/imm.12873",
language = "English",
volume = "154",
pages = "122--131",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells

AU - Schiavoni, Ilaria

AU - Scagnolari, Carolina

AU - Horenstein, Alberto L

AU - Leone, Pasqualina

AU - Pierangeli, Alessandra

AU - Malavasi, Fabio

AU - Ausiello, Clara M

AU - Fedele, Giorgio

N1 - © 2017 John Wiley & Sons Ltd.

PY - 2018/5

Y1 - 2018/5

N2 - Respiratory syncytial virus (RSV) is the most common cause of hospitalization due to bronchiolitis in infants. Although the mechanisms behind this association are not completely elucidated, they appear to involve an excessive immune response causing lung pathology. Understanding the host response to RSV infection may help in the identification of targets for therapeutic intervention. We infected in-vitro human monocyte-derived dendritic cells (DCs) with RSV and analysed various aspects of the cellular response. We found that RSV induces in DCs the expression of CD38, an ectoenzyme that catalyses the synthesis of cyclic ADPR (cADPR). Remarkably, CD38 was under the transcriptional control of RSV-induced type I interferon (IFN). CD38 and a set of IFN-stimulated genes (ISGs) were inhibited by the anti-oxidant N-acetyl cysteine. When CD38-generated cADPR was restrained by 8-Br-cADPR or kuromanin, a flavonoid known to inhibit CD38 enzymatic activity, RSV-induced type I/III IFNs and ISGs were markedly reduced. Taken together, these results suggest a key role of CD38 in the regulation of anti-viral responses. Inhibition of CD38 enzymatic activity may represent an encouraging approach to reduce RSV-induced hyperinflammation and a novel therapeutic option to treat bronchiolitis.

AB - Respiratory syncytial virus (RSV) is the most common cause of hospitalization due to bronchiolitis in infants. Although the mechanisms behind this association are not completely elucidated, they appear to involve an excessive immune response causing lung pathology. Understanding the host response to RSV infection may help in the identification of targets for therapeutic intervention. We infected in-vitro human monocyte-derived dendritic cells (DCs) with RSV and analysed various aspects of the cellular response. We found that RSV induces in DCs the expression of CD38, an ectoenzyme that catalyses the synthesis of cyclic ADPR (cADPR). Remarkably, CD38 was under the transcriptional control of RSV-induced type I interferon (IFN). CD38 and a set of IFN-stimulated genes (ISGs) were inhibited by the anti-oxidant N-acetyl cysteine. When CD38-generated cADPR was restrained by 8-Br-cADPR or kuromanin, a flavonoid known to inhibit CD38 enzymatic activity, RSV-induced type I/III IFNs and ISGs were markedly reduced. Taken together, these results suggest a key role of CD38 in the regulation of anti-viral responses. Inhibition of CD38 enzymatic activity may represent an encouraging approach to reduce RSV-induced hyperinflammation and a novel therapeutic option to treat bronchiolitis.

KW - ADP-ribosyl Cyclase 1/antagonists & inhibitors

KW - Antiviral Agents/therapeutic use

KW - Cells, Cultured

KW - Cyclic ADP-Ribose/metabolism

KW - Dendritic Cells/drug effects

KW - Enzyme Activation

KW - Enzyme Inhibitors/therapeutic use

KW - Host-Pathogen Interactions

KW - Humans

KW - Interferon Type I/metabolism

KW - Membrane Glycoproteins/antagonists & inhibitors

KW - Oxidative Stress

KW - Reactive Oxygen Species/metabolism

KW - Respiratory Syncytial Virus Infections/drug therapy

KW - Respiratory Syncytial Virus, Human/immunology

KW - Signal Transduction

U2 - 10.1111/imm.12873

DO - 10.1111/imm.12873

M3 - Article

C2 - 29178427

VL - 154

SP - 122

EP - 131

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 1

ER -